Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
5.54M
-
Shares change
-
+911K
-
Total reported value, excl. options
-
$57.6M
-
Value change
-
+$9.53M
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$10.40
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q3 2023
38 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q3 2023.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.54M shares
.
Largest 10 shareholders include Periscope Capital Inc. (616K shares), AQR Arbitrage LLC (450K shares), ATW SPAC MANAGEMENT LLC (311K shares), BOOTHBAY FUND MANAGEMENT, LLC (311K shares), Polar Asset Management Partners Inc. (260K shares), GLAZER CAPITAL, LLC (250K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (250K shares), Saba Capital Management, L.P. (250K shares), COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS (221K shares), and Exos TFP Holdings LLC (200K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.